NCT04701281View on ClinicalTrials.gov

Study of Intra-Arterial Oxaliplatin Plus Capecitabine to Treat Liver Metastases From Colorectal Cancer

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

March 2, 2022

Primary Completion Date

September 19, 2022

Study Completion Date

October 19, 2022

Conditions
Liver Metastasis Colon Cancer
Interventions
COMBINATION_PRODUCT

Intra-arterial LIOX + Capecitabine

5 - 7 LIOX (liver isolation oxaliplatin) intra-arterial infusions over 8 weeks + capecitabine

Trial Locations (5)

2065

GenesisCare, St Leonards, Saint Leonards

2076

Sydney Adventist Hospital, Sydney

2170

Sydney Southwest Private Hospital, Sydney

2290

Lake Macquarie Private Hospital, Gateshead

4215

Gold Coast Private Hospital, Southport

Sponsors

Lead Sponsor

AllVascular
All Listed Sponsors
lead

AllVascular

INDUSTRY

NCT04701281 - Study of Intra-Arterial Oxaliplatin Plus Capecitabine to Treat Liver Metastases From Colorectal Cancer | Biotech Hunter | Biotech Hunter